Single-cell mapping of combinatorial target antigens for CAR switches using logic gates-Reference-Cited by-同舟云学术

Single-cell mapping of combinatorial target antigens for CAR switches using logic gates

Published:2023-02-16 Issue:11 Volume:41 Page:1593-1605
ISSN:1087-0156
Container-title:Nature Biotechnology
language:en
Short-container-title:Nat Biotechnol

Author:

Kwon Joonha,Kang Junho,Jo Areum,Seo Kayoung,An Dohyeon,Baykan Mert Yakup,Lee Jun Hyeong,Kim Nayoung^ORCID,Eum Hye Hyeon,Hwang Sohyun,Lee Ji Min,Park Woong-Yang,An Hee Jung^ORCID,Lee Hae-Ock^ORCID,Park Jong-Eun^ORCID,Choi Jung Kyoon^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Biomedical Engineering,Molecular Medicine,Applied Microbiology and Biotechnology,Bioengineering,Biotechnology

Link

https://www.nature.com/articles/s41587-023-01686-y.pdf

Reference52 articles.

1. Sterner, R. C. & Sterner, R. M. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J. 11, 69 (2021).

2. Marofi, F. et al. CAR T cells in solid tumors: challenges and opportunities. Stem Cell Res. Ther. 12, 81 (2021).

3. Taylor, A. M. et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33, 676–689 (2018).

4. Fan, J. et al. Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data. Genome Res. 28, 1217–1227 (2018).

5. Patel, A. P. et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396–1401 (2014).

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy;Molecular Cancer;2024-06-01

2. Targeting solid tumor antigens with chimeric receptors: cancer biology meets synthetic immunology;Trends in Cancer;2024-04

3. Cellular nucleus image-based smarter microscope system for single cell analysis;Biosensors and Bioelectronics;2024-04

4. Altered tumor signature and T‐cell profile after chemotherapy reveal new therapeutic opportunities in high‐grade serous ovarian carcinoma;Cancer Science;2024-01-16

5. Profiling targets and potential target pairs of CAR-T cell therapy in clinical trials;International Immunopharmacology;2024-01